Pharmacokinetics and tolerability of single escalating doses of abituzumab in volunteers
Latest Information Update: 08 Jan 2014
At a glance
- Drugs Abituzumab (Primary)
- Indications Colorectal cancer; Ovarian cancer; Prostate cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Merck KGaA
- 08 Jan 2014 New trial record
- 19 Nov 2013 Results published in Investigational New Drugs.